Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Pharmaceutical

Active

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Indian Health Service has forecasted a pharmaceutical procurement opportunity under NAICS code 325411, indicating a focus on pharmaceutical and medicine manufacturing. This forecast, posted on May 25, 2026, is intended to inform potential vendors of an upcoming solicitation, though no specific solicitation number or set-aside details are currently available. The contract is expected to involve the supply of pharmaceutical products to support healthcare services for American Indian and Alaska Native communities. The point of contact for program-related inquiries is Gabriella Janke, while Misty Billy serves as the Contracting Officer. There is no specified place of performance or office address provided at this stage, suggesting the scope and location may be determined during the formal solicitation phase. Interested parties are encouraged to monitor the official OSDBU portal for future updates and detailed requirements.

General Info

Indian Health Service forecasts pharmaceutical supply contract opportunity; contact Gabriella Janke or Misty Billy.

Agency

Indian Health Service

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedMay 25

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyIndian Health Service

Contacts2 people available

OfficeN/A

Organization / Agency

Indian Health Service

Office AddressN/A

Contacts

Gabreilla Janke

contact@example.gov

Misty BillyContracting Officer

contact@example.gov

Full Description

Show more

2025-AAP-GSU-SU-0003: Pharmaceutical

Similar Contracts

Same NAICS industry code

REHYDRATION SALTS FORThe contract specifies the procurement of 5 packages of Rehydration Salts for Oral Solution, Orange Flavor, 21 grams each, under NSN 6505-01-687-1441, with a unit of issue of PACKAGE and a total value of $5.00. Delivery is required FOB destination within 20 days of contract award, with no variance allowed in quantity, and inspection and acceptance occur at the delivery point. The product must comply with strict packaging and labeling requirements per DLA’s Master List of Technical and Quality Requirements, specifically referencing Medical Marking Standard No. 1, which replaces MIL-STD-129, and must be commercially packaged in accordance with ASTM D3951 unless classified as hazardous, in which case Fed-Std-313 and IP025 apply. The item is a Type I (Code Q) medical product with a non-extendable shelf life of 36 months, and all packaging must be marked in full compliance with MMS No. 1, obtainable via DLA Troop Support or their public website. The destination for delivery is USS Tulsa (LCS-16), FPO AP 96691, with shipment handling governed by DLAD Proc Notes C19 and C20. The contract, issued under solicitation SPE2DP-26-T-4259, is for a federal acquisition with a response deadline of July 29, 2026, and the required delivery date is July 27, 2026. The supplier is Drip Drop Hydration Inc., identified by P/N 61410, and full technical and quality specifications are governed by DLA standards that supersede all other references.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SCOPOLAMINE TRANSDERMAThe contract specifies the procurement of 6 boxes of Scopolamine Transdermal System, each containing 10 patches delivering 1.5 mg over a three-day period, with the product identified by NSN 6505-01-692-5042 and NDC 10019-0553-03 from Baxter Healthcare Corporation. All units must be packaged in sealed commercial containers that protect against damage and breakage, shipped in suitable exterior containers to ensure safe, cost-effective delivery to Fort Bragg, North Carolina, within five days of contract award. Packaging must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and adhere to DLA Packaging Requirements for Procurement, including palletization and marking in accordance with the latest MMS No. 1 guidelines. The product has a non-extendable shelf life of 36 months and must be stored at controlled room temperature between 68°F and 77°F, with pouches kept upright and never bent or rolled. Delivery is FOB destination, with inspection and acceptance occurring at the delivery point, and no quantity variance is permitted. The shipment must be sent by the fastest traceable means, excluding parcel post, and all documentation must reflect the required government markings, logistics identifiers, and special handling instructions. The contract is issued under solicitation SPE2DP-26-T-4267 with a required delivery date of July 27, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE AND MENTHOLThe contract is for the procurement of Benzocaine and Menthol Lozenge, specifically CEPACOL EXTRA STRENGTH SORE THROAT HONEY LEMON LOZENGES, each containing 15 mg of benzocaine and 2.6 mg of menthol, packaged in quantities of 16 lozenges per unit. The product must be stored at 20–25°C (68–77°F) and protected from humidity. All packaging must comply with commercial standards as outlined in the procurement document, with each unit sealed in a container that prevents damage or breakage, and shipped in exterior containers that ensure safe, low-cost delivery by common carriers to the designated destination. Medical marking requirements follow Medical Marking Standard No. 1, which replaces MIL-STD-129, and suppliers must adhere to DLA’s packaging guidelines and shelf-life requirement of 36 months with no extensions permitted. The item is identified by NSN 6505-01-708-1449 and NDC 63824-0732-16, supplied by Reckitt Benckiser LLC and RB Health US LLC. Delivery is required within 20 days, FOB destination, with zero variance allowed in quantity and inspection and acceptance occurring upon delivery. The shipment must be traceable, excluding parcel post, and delivered to Fort Campbell, Kentucky. Special handling instructions, including palletization and packaging methods, must align with DLA’s technical and quality standards referenced in the Master List, and all markings and documentation must conform to required government protocols for medical acquisitions.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical Product Supply – Psyllium Hydrophilic MucilloidThe contract calls for the supply of FDA-regulated Psyllium Hydrophilic Mucilloid in 12-gram packets, with strict specifications for potassium and sodium content to ensure compliance with medical standards. Each packet must be manufactured under the part number NDC37000-0740-87 and carry a non-extendable 24-month shelf life, requiring careful production and inventory management to maintain product integrity through distribution and use. The product is intended for military medical use, with performance located at Camp Pendleton, California, 92055-5627, and is classified under NAICS code 325411 for pharmaceutical and medicine manufacturing. This subcontract is solicited by the Department of Defense under the Medical Supply Chain Pharm FSA, with responses due by July 28, 2026, and the posting date was July 22, 2026. No set-aside provisions apply, and the contract is open to qualified suppliers meeting all technical and regulatory requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets 100mg are procured under solicitation SPE2DP-26-T-4238 for acute treatment of migraine with or without aura in adults. The product must be supplied in bottles of nine tablets, stored at 20 to 25°C (68 to 77°F), protected from light, and adhere to a strict 24-month non-extendable shelf life as a Type I (Code M) medical item. Packaging and marking must comply with MIL-STD-2073-1E, MIL-STD-129, and DLA’s Medical Marking Standard No. 1, with palletization governed by DLA Packaging Requirements. The item is subject to FDA regulation and requires referral through EBS for confirmation. Two contract line items are listed: one for one bottle and another for five bottles, both with identical specifications, delivered FOB destination within five days, with no variance in quantity allowed. Delivery is directed to JBER, Alaska, with designated shipping and parcel post addresses provided. The required delivery date is July 24, 2026, and the contract includes detailed logistics codes, unit of issue references, and procurement identifiers. Manufacturer identifiers include NDC codes for Mylan Pharmaceuticals Inc and Golden State Medical Supply, Inc., and all technical and quality requirements referenced must align with the DLA Master List at the time of solicitation or award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PSYLLIUM HYDROPHILIThe contract is for the procurement of Psyllium Hydrophilic Mucilloid in 12 gram packets, each containing 25 mg potassium and 5 mg sodium, packaged in units of 30 packets per package, with a total requirement of 19,000 packets across multiple CLINs. The item is regulated by the FDA and must be supplied with the manufacturer’s part number NDC37000-0740-87 under The Procter & Gamble Distributing LLC. The product has a non-extendable shelf life of 24 months, and all packaging must comply with the latest Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must be labeled in accordance with DLA packaging requirements. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport by common carrier at the lowest cost. Delivery is FOB destination with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The contract requires precise marking, palletization, and traceable shipping methods, explicitly prohibiting parcel post. Delivery schedules vary by CLIN and are set between June 2025 and July 2026, with fulfillment addressed to multiple DoD locations including Camp Pendleton, Camp Kinsler, and the USS Pinckney. Bidders must specify their source and part number, and the contracting officer must refer the bid to a product specialist for FDA-regulated item confirmation. Technical and quality requirements are governed by the DLA Master List, and all documentation must align with the version in effect on the solicitation or award date.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Insect Repellent Supply for DoD UseThe contract entails the supply of 20 boxes of insect repellent standardized under NSN 6840016567707 for use by the Department of Defense, ensuring full compliance with Defense Logistics Agency packaging and delivery specifications. The product is classified under NAICS code 325411, indicating its origin in the manufacturing of other chemical products, and is being procured as a subcontract under the broader defense supply chain. Delivery must adhere strictly to DLA standards to ensure operational readiness and compatibility with military logistics systems. The contract was posted on July 21, 2026, and is tied to the award contract SPE4AX16D9008 with delivery identifier SPE4A626FCWRC, though no specific location or point of contact is provided. The effort supports the Department of Defense's mission-critical need for pest protection in deployment environments.

Defense Logistics Agency

POSTED

DEADLINE

TETRACAINE HYDROCHLThe contract is for Tetracaine Hydrochloride 1% Injection, 20mg/2ml (10mg/ml), preservative-free in 2ml single-use vials, with ten vials per package, requiring refrigerated storage. The item is classified under NSN 6505-01-708-3073 with a unit of issue of a package (PG) and a quantity of one package. It has a non-extendable shelf life of 36 months and must comply with the DLA Master List of Technical and Quality Requirements, including packaging standards per MIL-STD-2073-1E and marking requirements per Medical Marking Standard No. 1, which supersedes MIL-STD-129. The manufacturer is BPI, Inc. with NDC code 54288-0127-10, and the product is regulated by the FDA, requiring a referral through EBS for confirmation. Delivery is FOB destination within 20 days to Fort Campbell, Kentucky, and shipment must be via traceable means, excluding parcel post. Packaging must ensure protection from damage, use commercial containers, and meet DLA packaging requirements, with palletization and marking strictly adhering to specified protocols. The contract was issued under solicitation SPE2DP-26-T-4231 with a response deadline of July 27, 2026, and the required delivery date is March 5, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 21 hours

PSYLLIUM HYDROPHILIC MThe contract is for Psyllium Hydrophilic Mucilloid in sugar orange flavor, supplied in 12 gm packets, with each packet containing 25 mg of potassium and 5 mg of sodium, packaged in units of 30 packets per box. The item is regulated by the FDA and must be procured with the specified manufacturer part number NDC37000-0740-87 from The Procter & Gamble Distributing LLC. It carries a non-extendable 24-month shelf life under Type I (Code M) requirements and must be packaged and marked in strict accordance with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. Packaging must meet DLA requirements, including commercial-grade sealed unit containers and shipping containers that ensure safe delivery at the lowest possible rate. The unit of issue is a package of 30s, with a total quantity of 4 packages required. Delivery is FOB destination within 20 days, with zero variance permitted, and inspection and acceptance occur at the delivery point. The shipment is designated for a military vessel, with specific transportation protocols requiring the use of traceable methods and prohibiting parcel post. All labeling, packing, and marking must comply with applicable DLA standards, and bidders must clearly state the source and part number. The contract is issued under solicitation SPE2DP-26-T-4220 with an original delivery deadline of July 23, 2026, and is managed by the Department of Defense’s Medical Supply Chain PHARM FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 21 hours

VERAPAMIL HYDROCHLORIDVerapamil hydrochloride injection is a 5 mg per 2 mL (2.5 mg/mL) preservative-free, single-dose solution supplied in 2 mL glass flip-top vials, with a package quantity of 25 vials per unit. The product is intended solely for intravenous use and must be protected from light during storage and handling. It should be stored at a controlled room temperature of 20 to 25°C (68 to 77°F) in accordance with USP standards. The item has a non-extendable shelf life of 24 months from the date of manufacture, and no more than four months may have elapsed between manufacture and delivery to the government. The NSN is 6505-01-738-0226, and the purchase request number is 7017548722 with a delivery requirement of five days after order award. The contract is issued under solicitation number SPE2DP-26-T-4217, posted on July 21, 2026, with a response deadline of July 27, 2026. The NAICS code is 325411, and the contracting agency is the Department of Defense through the Medical Supply Chain Pharmaceutical FSA. Delivery is to Joint Base Elmendorf-Richardson in Alaska, 99506-4400. The contract incorporates technical and quality requirements from the DLA Master List and applies DLA packaging standards. Covered defense information may apply, and federal regulations require removal of government identification from non-accepted supplies. Primary point of contact is Daniel Porter, reachable by phone or email as listed.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 21 hours

SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets, 100mg in bottles of nine tablets, are procured under solicitation SPE2DP-26-T-4216 for the Department of Defense Medical Supply Chain, with a delivery requirement of five days after award and an original delivery date of July 22, 2026. The item, identified by NSN 6505017278704, is designated as a TYPE I (CODE M) medical product with a strict 24-month non-extendable shelf life, requiring storage at controlled room temperature between 20 to 25°C (68 to 77°F) and protection from light. The product is regulated by the FDA and must be accompanied by appropriate labeling per Medical Marking Standard No. 1 and MIL-STD-129, including barcoded identifiers, lot numbers, and expiration data. Packaging must comply with MIL-STD-2073-1E, utilizing prescribed preservation methods, unit containers, and intermediate packaging codes, with palletization governed by DLA’s RP001 requirements. All shipments must be delivered FOB destination to Fort Stewart, Georgia, or Joint Base Elmendorf-Richardson, Alaska, using the fastest traceable means, explicitly prohibiting parcel post. The contract mandates full compliance with FAR and DFARS clauses addressing labor rights, trafficking prevention, cybersecurity safeguards including NIST SP 800-171, hazardous material handling, and prohibitions on covered defense telecommunications equipment. Offerors must furnish valid UEI and CAGE codes, submit representations on small business status, and provide Safety Data Sheets aligned with Federal Standard No. 313 and OSHA’s Hazard Communication Standard. All invoices must be processed through WAWF, and inspection and acceptance occur at the delivery point with zero tolerance for quantity variance. The solicitation does not disclose unit pricing or total contract value, but specifies two line items totaling three bottles, with delivery scheduled for mid-2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Repackaging and Labeling ServicesThe contract involves the repackaging of fluconazole tablets into containers that meet Department of Defense compliance standards, ensuring proper military-specific labeling with National Stock Number, Technical Control Number, and military identification blocks. This work requires strict adherence to DoD packaging and labeling protocols to ensure accurate traceability, inventory control, and field distribution within military supply chains. The contractor must handle pharmaceuticals under appropriate conditions to maintain product integrity and regulatory compliance throughout the repackaging process. The performance of this subcontract falls under NAICS code 325411 for pharmaceutical and medicine manufacturing and is managed by the Defense Logistics Agency on behalf of the Department of Defense. While specific location details for performance or contact information are not provided, the contract is tied to a defined delivery and award mechanism through DLA’s procurement system, indicating it supports routine military pharmaceutical supply needs. The work is scheduled to be active following a public posting in July 2026, and the nature of the task suggests the contractor must possess experience in regulated pharmaceutical repackaging and familiarity with military logistical requirements.

Defense Logistics Agency

POSTED

DEADLINE